Kezar life sciences inc.

Major-Pharmaceuticals

KZR


4000 Shoreline Court
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 0.6
    $ -0.01 -1.8 %
    Aug 29, 2024
  • 52-Week High/Low
  • $1.57 - $0.56
  • YTD
  • -36.6%

  • Trading Volume
  • 4,910
  • Market Cap Full
  • $ 43.6M
  • Shares Outstanding
  • 72.7M
    Nov 4, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - -24.8% -5% 14.3% -0.6% -55.5% -4.8%
Q2 - - - -2.5% -60% 4% -8.9% -50.2% -21.7% -6.2%
Q3 - - - 24% -55.4% 8% 59.1% 4.1% -51.4% -
Q4 - - - 11.4% 30.7% 7.8% 93.5% -18.2% -17.7% -
J F M A M J J A S O N D
2024 4.5% 6.1% -14.1% -4.3% - - - - - - - -
2023 1.9% -12.3% -50.2% -22.4% 14.4% -11.9% -8.6% -33.5% -20.1% -39.4% 16.2% 13%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%-82%22%221%-58%-87%-37%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - -6.53 -0.4 -0.3 -0.25 -0.26 -0.31
Q2 - - - -3.31 -0.46 -0.22 -0.25 -0.25 -0.34
Q3 - - - -0.3 -0.48 -0.23 -0.28 -0.25 -0.32
Q4 - - - 7.88 -0.5 -0.2 -0.26 -0.25 -
A 0 0 0 -2.3 -1.8 -1 -1 -1 -0.97

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 19.1 38.2 48.1 56.7 70.8
Jun - 19.1 38.2 48.1 60.4 72.4
Sep 19.1 19.1 46.3 48.2 68.4 72.7
Dec 19.1 19.1 46.3 49.1 68.4 72.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - 0.1 - - -
Debt – Equity Ratio - 0.1 - - -
Interest Coverage 23.7 - 43 18.5 12.5
Equity multiplier - - - 0.1 0.1